Open access · OA
via Europe PMC
Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.
David Sarmento C, Drouard G, Saari TT, Aaltonen A, Heikkinen A, Hukkanen M, Palviainen T, Herukka SK, Kokkola T, Kärkkäinen S, FinnGen, Palotie A, Julkunen V, Runz H, Kaprio J
Alzheimer's & dementia (Amsterdam, Netherlands) · 2026 · ▲ 1 citations
Abstract
<h4>Introduction</h4>Proteomic aging clocks detect disease-related systemic and organ-specific changes and are easily accessible by minimally invasive blood draws. However, their potential in Alzheimer's disease (AD) assessment remains unestablished.<h4>Methods</h4>We investigated associations of proteomic and epigenetic clocks with AD-related blood-based biomarkers and cognitive tests. Omics were generated from blood samples of 153 cognitively unimpaired individuals (average age 62 years); blood biomarkers and cognition were measured approximately nine years after.<h4>Results</h4>Proteomic clocks explained up to 23% of variance in cognitive and biomarker measures not explained by epigenetics. Accelerated systemic and brain-specific proteomic aging were linked to poorer cognition and higher levels of plasma neurofilament light chain. Exploratory interaction analyses suggested weaker proteomic aging-cognition associations in individuals with higher genetic liability for diabetes.<h4>Discussion</h4>Our study illustrates the potential of plasma proteomic clocks in detecting AD-related phenotypes. However, co-morbidities possibly constitute confounding factors, compromising the performance of proteomic aging models.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/dad2.70456
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
C, D.S., G, D., TT, S., A, A., A, H., M, H., T, P., SK, H., T, K., S, K., FinnGen, A, P., V, J., H, R., J, K., M, O., & E., V. (2026). Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis. <em>Alzheimer's & dementia (Amsterdam, Netherlands)</em>. https://doi.org/10.1002/dad2.70456
Vancouver
C DS, G D, TT S, A A, A H, M H, et al. Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis. Alzheimer's & dementia (Amsterdam, Netherlands). 2026. doi:10.1002/dad2.70456.
BibTeX
@article{david2026Associ,
title = {Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.},
author = {David Sarmento C and Drouard G and Saari TT and Aaltonen A and Heikkinen A and Hukkanen M and Palviainen T and Herukka SK and Kokkola T and Kärkkäinen S and FinnGen and Palotie A and Julkunen V and Runz H and Kaprio J and Ollikainen M and Vuoksimaa E.},
journal = {Alzheimer's & dementia (Amsterdam, Netherlands)},
year = {2026},
doi = {10.1002/dad2.70456},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2026
Open access · CC-BY
Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis
medRxiv 2025
Preprint · CC-BY
Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory Analysis
Journal of Investigative Dermatology 2026
Citation only
Comparative Transcriptomic and Proteomic Profiling of Atopic Dermatitis Across Age Groups and Disease Severity Reveals Distinct Inflammatory Signatures
Nature Aging 2025
Citation only
Interplay of somatic mutations and epigenetic aging clocks
American Journal of Physiology-Lung Cellular and Molecular Physiology 2025
Open access · CC-BY
Epigenetic age acceleration in idiopathic pulmonary fibrosis revealed by DNA methylation clocks
Gaceta Médica de México 2025
Open access · CC-BY